Next Article in Journal
Dense Plasma Focus-Based Nanofabrication of III–V Semiconductors: Unique Features and Recent Advances
Previous Article in Journal
Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles
Previous Article in Special Issue
Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro
Open AccessReview

Receptor-Mediated Drug Delivery Systems Targeting to Glioma

Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China
*
Author to whom correspondence should be addressed.
Academic Editors: Subramanian Tamil Selvan, Wolfgang J. Parak and Pablo del Pino
Nanomaterials 2016, 6(1), 3; https://doi.org/10.3390/nano6010003
Received: 25 September 2015 / Revised: 8 November 2015 / Accepted: 24 November 2015 / Published: 28 December 2015
(This article belongs to the Special Issue Nanoparticles in Theranostics)
Glioma has been considered to be the most frequent primary tumor within the central nervous system (CNS). The complexity of glioma, especially the existence of the blood-brain barrier (BBB), makes the survival and prognosis of glioma remain poor even after a standard treatment based on surgery, radiotherapy, and chemotherapy. This provides a rationale for the development of some novel therapeutic strategies. Among them, receptor-mediated drug delivery is a specific pattern taking advantage of differential expression of receptors between tumors and normal tissues. The strategy can actively transport drugs, such as small molecular drugs, gene medicines, and therapeutic proteins to glioma while minimizing adverse reactions. This review will summarize recent progress on receptor-mediated drug delivery systems targeting to glioma, and conclude the challenges and prospects of receptor-mediated glioma-targeted therapy for future applications. View Full-Text
Keywords: glioma; blood-brain barrier (BBB); receptor-mediated; single ligand-modified targeting systems; dual ligand-modified targeting systems glioma; blood-brain barrier (BBB); receptor-mediated; single ligand-modified targeting systems; dual ligand-modified targeting systems
Show Figures

Graphical abstract

MDPI and ACS Style

Wang, S.; Meng, Y.; Li, C.; Qian, M.; Huang, R. Receptor-Mediated Drug Delivery Systems Targeting to Glioma. Nanomaterials 2016, 6, 3.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop